Invention Grant
- Patent Title: Chemoembolization agents
-
Application No.: US16616808Application Date: 2018-05-25
-
Publication No.: US11712418B2Publication Date: 2023-08-01
- Inventor: James Na , David Imagawa , Fabio Tucci , Graham Beaton , Satheesh Ravula
- Applicant: BRUIN BIOSCIENCES, INC. , THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
- Applicant Address: US CA San Diego
- Assignee: BRUIN BIOSCIENCES, INC.,THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
- Current Assignee: BRUIN BIOSCIENCES, INC.,THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
- Current Assignee Address: US CA San Diego; US CA Oakland
- Agency: Brooks Kushman PC
- Agent John E. Nemazi
- International Application: PCT/US2018/034744 2018.05.25
- International Announcement: WO2018/218208A 2018.11.29
- Date entered country: 2019-11-25
- Main IPC: A61K9/127
- IPC: A61K9/127 ; A61P35/00 ; A61K9/14 ; A61K9/50 ; A61K31/404 ; A61K31/44 ; A61K31/47 ; A61K31/53 ; A61K47/24
Abstract:
A chemoembolization therapy, which combines therapeutic effects of peripheral arterial occlusion with the local administration of an anti-cancer agent. A particle or microsphere occludes the arteries providing blood flow to the tumor, resulting in tumor oxygen deprivation. The anti-angiogenic agent is an anti-cancer drug.
Public/Granted literature
- US20210169801A1 CHEMOEMBOLIZATION AGENTS Public/Granted day:2021-06-10
Information query
